Funding for Federal Agencies Uncertain as Fiscal Year Deadline Approaches

Endocrine Society Rallies for Increased Funding for the National Institutes of Health

Congress is required to determine funding levels for all federal programs and agencies by October 1 when the new fiscal year begins. However, this year Congress is not on track to pass the 12 annual appropriations bills to fund the government by the deadline.

Consequently, it is expected that instead the Congress will resort to passing a stopgap spending bill, known as a Continuing Resolution (CR), that will allow the federal government to continue to operate at the previous year’s funding level. It is not clear how long that short-term bill would last before Congress could agree to final spending levels.

The House Freedom Caucus, a group of fiscally conservative Republicans wants to see current spending levels frozen until the next Congress is sworn in, banking on a GOP majority to legislate federal funding. In contrast, Democrats are arguing for a shorter-term CR with a final spending bill passed before the end of this year.

This year, the Hill Day will take place on September 14 with advocates meeting their congressional delegations in Washington, D.C. Together, we will continue to call on Congress to make funding for the NIH a national priority and raise awareness about the importance of continued investment in medical research.

The Endocrine Society continues to advocate for a final appropriations bill with increases for the National Institutes of Health. Every September, we join a broad coalition of groups representing the medical research advocacy community in a “Rally for Medical Research” Hill Day to urge members of Congress to make funding for the National Institutes of Health (NIH) a national priority.

This year, the Hill Day will take place on September 14 with advocates meeting their congressional delegations in Washington, D.C. Together, we will continue to call on Congress to make funding for the NIH a national priority and raise awareness about the importance of continued investment in medical research.

You may also like

  • August 2024 Endocrine Society Advocacy Update

    Revised Version of TROA Passes House Ways & Means Committee On June 27, 2024, the House Ways and Means Committee passed a revised version of the Treat and Reduce Obesity Act (TROA), legislation that would allow Medicare coverage of anti-obesity medications (AOMs), which currently is prohibited under law. The version that passed would only allow…

  • Endocrine Society Continues Global EDC Advocacy; EU Election Results Leaves Outcomes for EDC Legislation Uncertain  

    On June 17, the Endocrine Society joined delegations from dozens of countries gathered in Geneva, Switzerland, for the third session of an ad hoc open-ended working group (OEWG) convened under the United Nations Environment Programme (UNEP) to develop proposals to establish a new science policy panel charged with helping to inform governments, companies, farmers and…

Find more in